ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1187

$1.56M Total Retail Price of All Prescriptions

Rank: 11 out of 1187

963 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 963 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 963 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
PRAVASTATIN SODIUM 658 481 1 12
LEVOTHYROXINE SODIUM 625 471 2 3
OMEPRAZOLE 536 387 3 5
AMLODIPINE BESYLATE 535 438 4 2
ENALAPRIL MALEATE 530 387 5 27
FUROSEMIDE 526 473 6 8
SIMVASTATIN 495 335 7 1
LISINOPRIL 410 306 8 4
METOPROLOL TARTRATE 403 334 9 10
METFORMIN HCL 320 247 10 7
ZOLPIDEM TARTRATE 316 211 11 14
HYDROCODONE-ACETAMINOPHEN 275 133 S3 12 20
GABAPENTIN 257 186 13 23
ATENOLOL 256 215 14 18
FAMOTIDINE 249 202 15 48
GLIMEPIRIDE 246 192 16 30
MELOXICAM 210 145 17 49
CITALOPRAM HBR 206 163 18 45
ATORVASTATIN CALCIUM 203 166 19 6
CARVEDILOL 201 156 20 19
ALENDRONATE SODIUM 194 97 21 25
POTASSIUM CHLORIDE 192 152 22 32
METOPROLOL SUCCINATE 188 126 23 11
CRESTOR 178 132 24 16
NEXIUM 173 140 25 15
LOVASTATIN 154 122 26 83
OXYCODONE-ACETAMINOPHEN 153 109 S2 27 47
TRAZODONE HCL 146 81 28 63
METHYLPREDNISOLONE 138 106 29 104
WARFARIN SODIUM 137 102 30 13
HYDROCHLOROTHIAZIDE 136 109 31 9
AZITHROMYCIN 132 97 32 24
LOSARTAN POTASSIUM 132 125 32 21
TRAMADOL HCL 131 73 34 28
METFORMIN HCL ER 129 72 35 57
TAMSULOSIN HCL 125 94 36 29
FINASTERIDE 118 86 37 110
CIPROFLOXACIN HCL 117 89 38 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 113 39 39
SERTRALINE HCL 110 81 40 22
INSULIN SYRINGE 110 69 40 128
COMBIVENT 110 78 40 219
DIOVAN 107 75 43 17
NAMENDA 104 103 44 44
DONEPEZIL HCL 101 101 45 26
RAMIPRIL 100 89 46 36
CLOPIDOGREL 100 89 46 33
OXYBUTYNIN CHLORIDE 97 63 48 230
AMOXICILLIN 96 63 49 97
CELEBREX 95 78 50 68
LIPITOR 90 79 51 43
KLOR-CON 10 90 85 51 151
FLOVENT HFA 88 74 53 216
PLAVIX 86 78 54 52
VITAMIN D2 86 76 54 337
PREDNISONE 83 61 56 61
LANTUS 82 41 57 77
ALLOPURINOL 82 66 57 50
EVISTA 82 63 57 114
SPIRIVA 81 50 60 55
RISPERIDONE 79 50 61 58
SYNTHROID 76 68 62 46
VENLAFAXINE HCL ER 76 53 62 121
KLOR-CON M20 75 47 64 93
PEN NEEDLE 75 61 64 134
HYDROCODONE BIT-IBUPROFEN 75 53 S3 64 302
ACETAMINOPHEN-CODEINE 74 62 S3 67 105
SINGULAIR 74 52 67 67
ISOSORBIDE MONONITRATE ER 72 62 69 66
LACTULOSE 71 51 70 96
ADVAIR DISKUS 70 51 71 35
DILTIAZEM 24HR ER 68 57 72 156
OXYCODONE HCL 67 14 S2 73 38
PROAIR HFA 65 24 74 41
OXYCONTIN 65 27 S2 74 76
IBUPROFEN 64 36 76 59
MORPHINE SULFATE ER 64 0 S2 76 124
NYSTATIN-TRIAMCINOLONE 63 44 78 208
DIGOXIN 60 51 79 65
METOCLOPRAMIDE HCL 58 26 80 159
PANTOPRAZOLE SODIUM 58 47 80 42
CEPHALEXIN 57 40 82 176
AMLODIPINE BESYLATE-BENAZEPRIL 56 54 83 62
VERAPAMIL ER 56 53 83 147
ROPINIROLE HCL 54 38 85 180
PAROXETINE HCL 54 31 85 81
DOXAZOSIN MESYLATE 53 44 87 167
POLYETHYLENE GLYCOL 3350 53 34 87 86
VESICARE 53 45 87 176
LOVAZA 52 36 90 53
MIRTAZAPINE 51 46 91 54
AMITRIPTYLINE HCL 50 35 R 92 190
PHENYTOIN SODIUM EXTENDED 50 23 92 173
CYMBALTA 50 41 92 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.